Funding Rounds
AgomAb Therapeutics

AgomAb Therapeutics Series C (2023, $100M)

AgomAb Therapeutics

Drug discovery platform for fibrotic diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →